Targeting CD11b+ Myeloid Cell Recruitment Therapeutically Treats Lupus Nephritis via Reductions in Soluble Urokinase Plasminogen Activator Receptor (suPAR) and C-C Motif Ligand 2 (CCL2) Levels: TH-PO0687
Xiaobo Li, Billy Nguyen, Nishant Ranjan, Santiago Balza Pineda, Mohamed A. Youssef, Brenna Knott, David Changli Wei, Darlah M. Lopez-Rodriguez, Shikha Wadhwani, Salim Hayek, …
Journal of the American Society of Nephrology, Vol.36(10S), 10.1681/ASN.2025jq1mwqv8